Bellus Health

Investors & Media

Press Releases

Press Releases

6/1/22
BELLUS Health to Participate in the Jefferies Healthcare Conference
LAVAL, Quebec --(BUSINESS WIRE)--Jun. 1, 2022-- BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) (“BELLUS Health” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough (“RCC”) and other cough hypersensitivity indications,
Displaying 1 - 10 of 14